Hua Medicine has announced the first innovative diabetes drug, Dozaglietin. (Dorzagliatin's NDA application was accepted by the National Medical Products Administration's (NMPA) Center for...
The pharmaceutical company Eli Lilly has signed a series of contracts with four diabetes management companies to integrate them into the upcoming Tempo Pen...